Journals / Nöropsikiyatri Arşivi / 2016 / Cilt: 53 - Sayı: 3

Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R)

Amiyotrofik Lateral Skleroz Fonksiyonel Derecelendirme Skalası'nın Türkçe'ye Uyarlanması ve Güvenirlilik Çalışması

Pages
229–233
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It was shown in the present study that in the clinical follow-up of the disease, the Turkish version of ALSFRS-R is a simple, reliable, and easily applicable.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by progressive degeneration of the motor neurons.
📊
Key Findings & Data:The present study was designed to evaulate the validity of the Turkish version of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), which has been used in various countries for measuring the functional status of ALS patients.Methods: The ALSFRS-R scores of 41 ALS patients (24 male), in any stages of illness, were simultaneously assessed by two physicians.
💡
Conclusion & Impact:Conclusion: It was shown in the present study that in the clinical follow-up of the disease, the Turkish version of ALSFRS-R is a simple, reliable, and easily applicable.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by progressive degeneration of the motor neurons. It is difficult to define the severity of the clinical findings of this destructive disease owing to its rapid progression, which presents serious alterations in a short time even in the same patient. The present study was designed to evaulate the validity of the Turkish version of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), which has been used in various countries for measuring the functional status of ALS patients.Methods: The ALSFRS-R scores of 41 ALS patients (24 male), in any stages of illness, were simultaneously assessed by two physicians. The functional status of the patients (motor system, bulbar, and pulmonary functions) was evaluated under 12 titles. In every subtitle, the functional status was evaluated as 0 for the worst functional status and 4 for the best functional status. The mean differentials for both subtitles and global scores and the 95% confidence bounds of these means were detected. The coherence was defined as the states in which the coefficient is above 0.80 and is statistically significant. Results: From the data obtained, the correlation between the two physicians was found to be statistically significant (p=0.000) in terms of the means of both subtitles and total scores. Conclusion: It was shown in the present study that in the clinical follow-up of the disease, the Turkish version of ALSFRS-R is a simple, reliable, and easily applicable.

Özet

Amaç: Amiyotrofik Lateral Skleroz (ALS) motor nöronların ilerleyici dejenerasyonu ile seyreden ölümcül bir hastalıktır. Yıkımla seyreden bu hastalığın klinik bulgularının ağırlığını tanımlamak oldukça güç olup, hızlı progresyonu nedeni ile aynı hastada bile kısa süre içerisinde ciddi değişiklikler göstermektedir. Bu çalışmada çeşitli ülkelerde ALS'li hastaların fonksiyonel durumunu ölçmede yaygın olarak kullanılan Revize Edilmiş Amiyotrofik Lateral Skleroz Fonksiyonel Derecelendirme Skalasının (ALSFDS-R) Türkçe versiyonunun güvenirliliğini ölçmek amaçlanmıştır Yöntem: Hastalığın herhangi bir evresinde olan ALS'li 41 hastada (24'ü erkek 17'si kadın) ALSFDS-R eş zamanlı olarak iki hekim tarafından değerlendirildi ve skorları hesaplandı. Hastaların fonksiyonel durumları (motor sistem, bulber ve pulmoner fonksiyonlar) on iki başlık ile ele alındı. Her alt başlıkta fonksiyonel olarak en kötü durum 0 puan, fonksiyonel olarak en iyi durum ise 4 puan ile değerlendirildi. Hem alt başlıklar hem de global skorlar açısından fark ortalaması ve bu ortalamanın %95'lik güven aralıkları bulundu. Katsayının 0,80'den büyük ve istatistiksel anlamlı olduğu durumlar 'uyum' olarak tanımlandı Bulgular: Elde edilen verilerden her iki hekim arasındaki uyum hem alt başlıklar hem de toplam skor açısından istatistiksel olarak anlamlı (p=0,000) bulundu. Sonuç: Yapılan bu çalışma ile hastalığın klinik takibinde ALSFDS-R'nin Türkçe versiyonunun basit, güvenilir ve kolay uygulanabilir bir test olduğu gösterilmiştir.

🔖

Cite This Article

KOÇ, A. F., BALAL, M., DEMİR, T., ALPARSLAN, Z. N., SARICA, Y. (2016). Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R). Nöropsikiyatri Arşivi, Cilt: 53 - Sayı: 3, 229–233. https://ajindex.com/articles/292413

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insi- ghts from genetics. Nat Rev Neurosci 2006; 7:710-723. [CrossRef] Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011; 7:616-630. [CrossRef] Özoğuz A, Uyan Ö, Birdal G, İskender C, Kartal E, Lahut S, Ömür Ö, Agim ZS, Eken AG, Sen NE, Kavak P, Saygı C, Sapp PC, Keagle P, Parman Y, Tan E, Koç F, Deymeer F, Oflazer P, Hanağası H, Gürvit H, Bilgiç B, Durmuş H, Ertaş M, Kotan D, Akalın MA, Güllüoğlu H, Zarifoğlu M, Aysal F, Döşoğlu N, Bilguvar K, Günel M, Keskin Ö, Akgün T, Özçelik H, Landers JE, Brown RH, Başak AN. The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiol Aging 2015; 36:9-18. [CrossRef] Koç F, Sarıca Y, Bozdemir H. Amyotrophic Lateral Sclerosis: Clinical analysis of 74 cases. Journal of Neurological Sciences 2004; 21:11-18.
  2. Pouget J, Azulay JP, Bille-Ture F. The diagnosis of amyotrophic lateral sclerosis. patogenesis and therapy of amyotrophic lateral sclerosis. Advances in Neuro- logy 1995; 88:143-152.
  3. Matsumoto S, Hirano A, Goto S. Spinal cord neurofibrillary tangles of Gua- manian amyortophic lateral sclerosis and parkinsonism-demantia complex: An immunohistochemical study. Neurology 1990; 40:975-979. [CrossRef] Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrop- hic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol 2013; 12:368-380. [CrossRef] Jesse M, Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that in- corporates assessments of respiratory function. J Neurol Sci 1999; 169:13-21. [CrossRef] Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, Gordon PH, Row- land LP, Levin B, Mitsumoto H. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005; 64:38-43. [CrossRef] Dougan CF, Connell E, Thornton E, Young CA. Development of a patient-spe- cific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS). J Neurol Sci 2000; 180:86-93. [CrossRef] Campos TS, Rodríguez SF, Esteban J, Vázquez PC, Mora Pardina JS, Carmona AC. Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Functi- onal Rating Scale (ALSFRS-R). Amyotroph Lateral Scler 2010; 11:475-477. [CrossRef] Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S, Sumino S,